5 Results for "

heat stroke

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "heat stroke" in MCE Product Catalog:

  • Targets Recommended:
6
6 Cited Publications
Cat. No.: HY-101712
CAS No.: 867164-40-7
Purity:  99.79%
Target:  

HSP

Research Areas:  

Neurological Disease

TRC051384 is a potent inducer of heat shock protein 70 (HSP70). TRC051384 exhibits protective effects against neuronal trauma via inhibition of necroptosis. TRC051384 can be used for the research of ischemic stroke .
loading...
    loading...
Cat. No.: HY-141564
CAS No.: 2837939-81-6
Target:  

Calcium Channel

Research Areas:  

Neurological Disease

RyR1-IN-1 (Compound 1) is a RyR1 inhibitor with an IC50 of 12 nM. RyR1-IN-1 blocks Ca²⁺ release and inhibits muscle tetany caused by caffeine and heat stress. RyR1-IN-1 can completely prevent the increase in body temperature and death caused by isoflurane and heat stress. RyR1-IN-1 can be used for the study of heat stroke .
loading...
    loading...
Cat. No.: HY-124109
CAS No.: 1333327-56-2
Target:  

HSP

TRC051384 hydrochloride is a potent inducer of heat shock protein 70 (HSP70). TRC051384 hydrochloride exhibits protective effects against neuronal trauma via inhibition of necroptosis. TRC051384 hydrochloride can be used for the research of ischemic stroke .
loading...
    loading...
Cat. No.: HY-101712R
CAS No.: 867164-40-7
Target:  

Reference Standards HSP

Research Areas:  

Neurological Disease

TRC051384 (Standard) is the analytical standard of TRC051384 (HY-101712). This product is intended for research and analytical applications. TRC051384 is a potent inducer of heat shock protein 70 (HSP70). TRC051384 exhibits protective effects against neuronal trauma via inhibition of necroptosis. TRC051384 can be used for the research of ischemic stroke .
loading...
    loading...
Cat. No.: HY-184108
CAS No.: 2486316-20-3
Research Areas:  

Neurological Disease

ZL006-05 is an orally active, brain-penetrant nNOS–PSD-95 and α2-containing GABAA dual-target inhibitor. ZL006-05 blocks the nNOS-PSD-95 protein-protein interaction and selectively potentiatesα2-containing GABAA receptors. ZL006-05 attenuates central sensitization and strengthens inhibitory GABAergic synaptic transmission. ZL006-05 can be used for the study of neuropathic pain, cancer pain, chemotherapy-induced peripheral neuropathic pain, ischemic stroke, poststroke depression and anxiety .
loading...
    loading...